| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
|
Suidan, Georgette L.
|
|
|
|
9 |
p. 954-963
|
artikel
|
| 2 |
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
|
Awan, Farrukh T.
|
|
|
|
9 |
p. 1553-1562
|
artikel
|
| 3 |
Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1–infected cells
|
Ikebe, Emi
|
|
|
|
9 |
p. 1845-1858
|
artikel
|
| 4 |
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells
|
Michelozzi, Ilaria M.
|
|
|
|
9 |
p. 1725-1738
|
artikel
|
| 5 |
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy
|
LoCastro, Marissa
|
|
|
|
9 |
p. 1871-1884
|
artikel
|
| 6 |
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
|
Gardin, Claude
|
|
|
|
9 |
p. 1942-1949
|
artikel
|
| 7 |
Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1
|
Ramassamy, Jill-Léa
|
|
|
|
9 |
p. 2044-2048
|
artikel
|
| 8 |
Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
|
|
|
|
|
9 |
p. 2812
|
artikel
|
| 9 |
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
|
Bloedjes, Timon A.
|
|
|
|
9 |
p. 1697-1712
|
artikel
|
| 10 |
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
|
Gouni, Sushanth
|
|
|
|
9 |
p. 2757-2762
|
artikel
|
| 11 |
Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo
|
Zhu, Min
|
|
|
|
9 |
p. 1014-1021
|
artikel
|
| 12 |
Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry
|
Kemble, Samuel
|
|
|
|
9 |
p. 2932-2946
|
artikel
|
| 13 |
A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD
|
Shi, Qizhen
|
|
|
|
9 |
p. 2778-2790
|
artikel
|
| 14 |
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation
|
Wan, Jun
|
|
|
|
9 |
p. 1915-1925
|
artikel
|
| 15 |
Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin
|
Dabas, Rosy
|
|
|
|
9 |
p. 1394-1405
|
artikel
|
| 16 |
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
|
Guglielmelli, Paola
|
|
|
|
9 |
p. 2927-2931
|
artikel
|
| 17 |
ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint
|
Kekre, Natasha
|
|
|
|
9 |
p. 573-576
|
artikel
|
| 18 |
ATG in allogeneic stem cell transplantation: standard of care in 2017? Point
|
Bacigalupo, Andrea
|
|
|
|
9 |
p. 569-572
|
artikel
|
| 19 |
A user guide to the American Society of Hematology clinical practice guidelines
|
Izcovich, Ariel
|
|
|
|
9 |
p. 2095-2110
|
artikel
|
| 20 |
Bai X, Huang L, Niu L, et al. Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels. Blood Adv. 2016;1(3):219-230.
|
|
|
|
|
9 |
p. 1844
|
artikel
|
| 21 |
Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease
|
Page, Kristin M.
|
|
|
|
9 |
p. 2947-2956
|
artikel
|
| 22 |
BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
|
Espada, Eduardo
|
|
|
|
9 |
p. 1881-1893
|
artikel
|
| 23 |
Bone marrow transplantation prevents right ventricle disease in the caveolin-1–deficient mouse model of pulmonary hypertension
|
Asosingh, Kewal
|
|
|
|
9 |
p. 526-534
|
artikel
|
| 24 |
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
|
Picardi, M.
|
|
|
|
9 |
p. 1546-1552
|
artikel
|
| 25 |
Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responses
|
Lopez Robles, Maria Dolores
|
|
|
|
9 |
p. 557-568
|
artikel
|
| 26 |
Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
|
Iijima, Mayuko
|
|
|
|
9 |
p. 2824-2834
|
artikel
|
| 27 |
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease
|
Martin de Frémont, Gregoire
|
|
|
|
9 |
p. 1682-1691
|
artikel
|
| 28 |
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function
|
Trory, Justin S.
|
|
|
|
9 |
p. 1692-1696
|
artikel
|
| 29 |
Childhood use of antimicrobials and risk of Hodgkin lymphoma: a Danish register–based cohort study
|
Hjalgrim, Henrik
|
|
|
|
9 |
p. 1489-1492
|
artikel
|
| 30 |
CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
|
Lucas, Claire M.
|
|
|
|
9 |
p. 964-968
|
artikel
|
| 31 |
Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease
|
Srisuwananukorn, Andrew
|
|
|
|
9 |
p. 1978-1986
|
artikel
|
| 32 |
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
|
Patel, Sanjay S.
|
|
|
|
9 |
p. 1540-1545
|
artikel
|
| 33 |
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
|
Carreño-Tarragona, Gonzalo
|
|
|
|
9 |
p. 1672-1681
|
artikel
|
| 34 |
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
|
Al Malki, Monzr M.
|
|
|
|
9 |
p. 2073-2083
|
artikel
|
| 35 |
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
|
Lachowiez, Curtis A.
|
|
|
|
9 |
p. 1899-1909
|
artikel
|
| 36 |
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies
|
Müller-Calleja, Nadine
|
|
|
|
9 |
p. 979-986
|
artikel
|
| 37 |
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
|
Bohl, Stephan R.
|
|
|
|
9 |
p. 2391-2402
|
artikel
|
| 38 |
Cord blood power and the definition of success after BMT
|
Boelens, Jaap Jan
|
|
|
|
9 |
p. 1811-1812
|
artikel
|
| 39 |
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
|
Martinez, Caridad
|
|
|
|
9 |
p. 1823-1830
|
artikel
|
| 40 |
CRISPR-edited megakaryocytes for rapid screening of platelet gene functions
|
Montenont, Emilie
|
|
|
|
9 |
p. 2362-2374
|
artikel
|
| 41 |
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia
|
Izaguirre-Carbonell, Jesus
|
|
|
|
9 |
p. 1499-1511
|
artikel
|
| 42 |
Curing CLL: one clone at a time
|
Aslan, Burcu
|
|
|
|
9 |
p. 1926-1928
|
artikel
|
| 43 |
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
|
Al Zaki, Ajlan
|
|
|
|
9 |
p. 2867-2871
|
artikel
|
| 44 |
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
|
Einarsdottir, Sigrun
|
|
|
|
9 |
p. 2723-2730
|
artikel
|
| 45 |
Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis
|
Young, David J.
|
|
|
|
9 |
p. 2285-2293
|
artikel
|
| 46 |
Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes
|
Lin, Kimberly
|
|
|
|
9 |
p. 2049-2057
|
artikel
|
| 47 |
Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
|
Blondon, Marc
|
|
|
|
9 |
p. 2884-2892
|
artikel
|
| 48 |
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease
|
Leonard, Alexis
|
|
|
|
9 |
p. 2403-2411
|
artikel
|
| 49 |
Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients
|
Ren, Weicheng
|
|
|
|
9 |
p. 2731-2744
|
artikel
|
| 50 |
Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia
|
Wang, Min
|
|
|
|
9 |
p. 1416-1428
|
artikel
|
| 51 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 52 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 53 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 54 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 55 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 56 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 57 |
Editorial Board
|
|
|
|
|
9 |
p. i
|
artikel
|
| 58 |
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL
|
Strati, Paolo
|
|
|
|
9 |
p. 1533-1539
|
artikel
|
| 59 |
Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia
|
Nasimuzzaman, Md
|
|
|
|
9 |
p. 1519-1532
|
artikel
|
| 60 |
Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model
|
Lay, Angelina J.
|
|
|
|
9 |
p. 1650-1665
|
artikel
|
| 61 |
Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment
|
Panetti, Silvia
|
|
|
|
9 |
p. 1754-1761
|
artikel
|
| 62 |
Fanciullino R, Farnault L, Donnette M, et al. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. Blood Adv. 2018;2(5):462-469.
|
|
|
|
|
9 |
p. 1013
|
artikel
|
| 63 |
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
|
Pinnix, Chelsea C.
|
|
|
|
9 |
p. 1356-1367
|
artikel
|
| 64 |
Front Matter
|
|
|
|
|
9 |
p. ii
|
artikel
|
| 65 |
FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice
|
Shrestha, Archana
|
|
|
|
9 |
p. 2385-2390
|
artikel
|
| 66 |
Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity
|
Payen, Mathilde
|
|
|
|
9 |
p. 1824-1832
|
artikel
|
| 67 |
FVIII half-life extension by coadministration of a D′D3 albumin fusion protein in mice, rabbits, rats, and monkeys
|
Pestel, Sabine
|
|
|
|
9 |
p. 1870-1880
|
artikel
|
| 68 |
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
|
De Smedt, Eva
|
|
|
|
9 |
p. 2325-2338
|
artikel
|
| 69 |
Generation of transgenic zebrafish with 2 populations of RFP- and GFP-labeled thrombocytes: analysis of their lipids
|
Fallatah, Weam
|
|
|
|
9 |
p. 1406-1415
|
artikel
|
| 70 |
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
|
Chovanec, Jack
|
|
|
|
9 |
p. 1796-1810
|
artikel
|
| 71 |
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
|
Nguyen, Nam H. K.
|
|
|
|
9 |
p. 1769-1783
|
artikel
|
| 72 |
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants
|
Kumar, Anita J.
|
|
|
|
9 |
p. 1022-1031
|
artikel
|
| 73 |
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
|
Mehta, Rohtesh S.
|
|
|
|
9 |
p. 1441-1449
|
artikel
|
| 74 |
Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective
|
Kelley, Rachel A.
|
|
|
|
9 |
p. 1813-1822
|
artikel
|
| 75 |
Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results
|
Adesina, Oyebimpe O.
|
|
|
|
9 |
p. 1476-1488
|
artikel
|
| 76 |
High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis
|
Lombardo, Katharine A.
|
|
|
|
9 |
p. 535-544
|
artikel
|
| 77 |
Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”?
|
Brunner, Andrew M.
|
|
|
|
9 |
p. 2854-2866
|
artikel
|
| 78 |
Huang L, Sun X, Yang D, et al. WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 2020;4(3):573-585.
|
|
|
|
|
9 |
p. 1916
|
artikel
|
| 79 |
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy
|
Gonzalez, Michael A.
|
|
|
|
9 |
p. 1849-1853
|
artikel
|
| 80 |
Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice
|
Kasztan, Malgorzata
|
|
|
|
9 |
p. 1460-1475
|
artikel
|
| 81 |
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review
|
Bataillard, Edward J.
|
|
|
|
9 |
p. 2426-2437
|
artikel
|
| 82 |
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
|
Harkins, R. Andrew
|
|
|
|
9 |
p. 2745-2756
|
artikel
|
| 83 |
Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells
|
Wang, Xiaomei
|
|
|
|
9 |
p. 1950-1964
|
artikel
|
| 84 |
Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy
|
Sigurdsson, Valgardur
|
|
|
|
9 |
p. 1833-1843
|
artikel
|
| 85 |
Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1
|
Quirino-Teixeira, Anna Cecíllia
|
|
|
|
9 |
p. 2018-2031
|
artikel
|
| 86 |
Infused factor VIII–expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A
|
Lyde, Randolph B.
|
|
|
|
9 |
p. 1368-1378
|
artikel
|
| 87 |
Kindlin-3 deficiency leads to impaired erythropoiesis and erythrocyte cytoskeleton
|
Szpak, Dorota
|
|
|
|
9 |
p. 1739-1753
|
artikel
|
| 88 |
Laboratory monitoring of hemophilia A treatments: new challenges
|
Lenting, Peter J.
|
|
|
|
9 |
p. 2111-2118
|
artikel
|
| 89 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
|
Clerici, Daniela
|
|
|
|
9 |
p. 1621-1634
|
artikel
|
| 90 |
LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα
|
Kohrogi, Kensaku
|
|
|
|
9 |
p. 2305-2318
|
artikel
|
| 91 |
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
|
Kennedy, Vanessa E.
|
|
|
|
9 |
p. 1713-1724
|
artikel
|
| 92 |
Maternal microchimerism protects hemophilia A patients from inhibitor development
|
Lu, Yeling
|
|
|
|
9 |
p. 1867-1869
|
artikel
|
| 93 |
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match
|
Giri, Jayeeta
|
|
|
|
9 |
p. 1987-1997
|
artikel
|
| 94 |
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia
|
Kaeding, Allison J.
|
|
|
|
9 |
p. 2350-2361
|
artikel
|
| 95 |
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
|
Wessels, Marja W.
|
|
|
|
9 |
p. 2339-2349
|
artikel
|
| 96 |
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
|
Choe, Sung
|
|
|
|
9 |
p. 1894-1905
|
artikel
|
| 97 |
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
|
Wise, Jillian F.
|
|
|
|
9 |
p. 1859-1866
|
artikel
|
| 98 |
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
|
Hsieh, Matthew M.
|
|
|
|
9 |
p. 2058-2063
|
artikel
|
| 99 |
Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML
|
Steinauer, Nickolas
|
|
|
|
9 |
p. 1379-1393
|
artikel
|
| 100 |
Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice
|
Campos, Joana
|
|
|
|
9 |
p. 2319-2324
|
artikel
|
| 101 |
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects
|
Rawley, Orla
|
|
|
|
9 |
p. 2908-2919
|
artikel
|
| 102 |
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
|
Tomowiak, Cécile
|
|
|
|
9 |
p. 2438-2446
|
artikel
|
| 103 |
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
|
Eertink, J.J.
|
|
|
|
9 |
p. 2375-2384
|
artikel
|
| 104 |
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
|
Osman, Afaf E. G.
|
|
|
|
9 |
p. 1910-1914
|
artikel
|
| 105 |
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
|
Leppä, Sirpa
|
|
|
|
9 |
p. 1906-1915
|
artikel
|
| 106 |
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
|
Jankowski, Wojciech
|
|
|
|
9 |
p. 1429-1440
|
artikel
|
| 107 |
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
|
Lee, Je-Hwan
|
|
|
|
9 |
p. 2032-2043
|
artikel
|
| 108 |
Phthalides serve as potent modulators to boost fetal hemoglobin induction therapy for β-hemoglobinopathies
|
Chen, Wei-Ren
|
|
|
|
9 |
p. 1493-1498
|
artikel
|
| 109 |
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
|
Naeem, Aishath
|
|
|
|
9 |
p. 1929-1943
|
artikel
|
| 110 |
Poor tolerability to ponatinib in Indian CML patients
|
Singh, Charanpreet
|
|
|
|
9 |
p. 1927-1929
|
artikel
|
| 111 |
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
|
Heuser, Michael
|
|
|
|
9 |
p. 2294-2304
|
artikel
|
| 112 |
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
|
Le, Quy
|
|
|
|
9 |
p. 1666-1670
|
artikel
|
| 113 |
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
|
Versluis, Jurjen
|
|
|
|
9 |
p. 2835-2846
|
artikel
|
| 114 |
Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura
|
Sun, Lova
|
|
|
|
9 |
p. 1512-1518
|
artikel
|
| 115 |
Profilin 1–mediated cytoskeletal rearrangements regulate integrin function in mouse platelets
|
Stritt, Simon
|
|
|
|
9 |
p. 1040-1045
|
artikel
|
| 116 |
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
|
Ceraulo, Antony
|
|
|
|
9 |
p. 2773-2777
|
artikel
|
| 117 |
Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma
|
Matsue, Kosei
|
|
|
|
9 |
p. 1032-1039
|
artikel
|
| 118 |
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication
|
Paul, Helmut
|
|
|
|
9 |
p. 1831-1848
|
artikel
|
| 119 |
Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease
|
Lee, Margaret T.
|
|
|
|
9 |
p. 969-978
|
artikel
|
| 120 |
Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy
|
Humbert, Olivier
|
|
|
|
9 |
p. 987-999
|
artikel
|
| 121 |
Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn
|
Aziz-Bose, Rahela
|
|
|
|
9 |
p. 2893-2896
|
artikel
|
| 122 |
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
|
Northend, Michael
|
|
|
|
9 |
p. 2920-2926
|
artikel
|
| 123 |
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea
|
Zouali, Habib
|
|
|
|
9 |
p. 2805-2811
|
artikel
|
| 124 |
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
|
Ansell, Stephen M.
|
|
|
|
9 |
p. 1917-1926
|
artikel
|
| 125 |
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant
|
Rubinstein, Jeremy D.
|
|
|
|
9 |
p. 2897-2907
|
artikel
|
| 126 |
Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198-3225.
|
|
|
|
|
9 |
p. 1671
|
artikel
|
| 127 |
SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD–mutant AML
|
Pacharne, Suruchi
|
|
|
|
9 |
p. 2412-2425
|
artikel
|
| 128 |
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
|
Olsen, Kelly S.
|
|
|
|
9 |
p. 1635-1649
|
artikel
|
| 129 |
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
|
Schoettler, Michelle
|
|
|
|
9 |
p. 1784-1795
|
artikel
|
| 130 |
Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry
|
Moulis, Guillaume
|
|
|
|
9 |
p. 1974-1977
|
artikel
|
| 131 |
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition
|
Maslah, Nabih
|
|
|
|
9 |
p. 2813-2823
|
artikel
|
| 132 |
Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD
|
Piper, Clint
|
|
|
|
9 |
p. 2791-2804
|
artikel
|
| 133 |
Soluble urokinase-type plasminogen activator receptor in sickle cell disease–associated chronic kidney disease
|
Afangbedji, Nowah
|
|
|
|
9 |
p. 1854-1857
|
artikel
|
| 134 |
Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib
|
Morgan, Juliet
|
|
|
|
9 |
p. 1450-1459
|
artikel
|
| 135 |
Structure of shear-induced platelet aggregated clot formed in an in vitro arterial thrombosis model
|
Kim, Dongjune A.
|
|
|
|
9 |
p. 2872-2883
|
artikel
|
| 136 |
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
|
Kahn, Justine M.
|
|
|
|
9 |
p. 2084-2094
|
artikel
|
| 137 |
Survival following allogeneic transplant in patients with myelofibrosis
|
Gowin, Krisstina
|
|
|
|
9 |
p. 1965-1973
|
artikel
|
| 138 |
Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia
|
Imi, Tatsuya
|
|
|
|
9 |
p. 1000-1012
|
artikel
|
| 139 |
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis
|
Felber, Matthias
|
|
|
|
9 |
p. 1998-2010
|
artikel
|
| 140 |
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
|
de Botton, Stéphane
|
|
|
|
9 |
p. 1858-1870
|
artikel
|
| 141 |
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones
|
Shaw, Lauren C.
|
|
|
|
9 |
p. 1885-1898
|
artikel
|
| 142 |
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
|
Assouline, Sarit
|
|
|
|
9 |
p. 2011-2017
|
artikel
|
| 143 |
The sialyltransferase ST3Gal-IV guides murine T-cell progenitors to the thymus
|
Sitte, Selina
|
|
|
|
9 |
p. 1930-1941
|
artikel
|
| 144 |
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
|
Weinberg, Olga K.
|
|
|
|
9 |
p. 2847-2853
|
artikel
|
| 145 |
Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
|
Qi, Shunan
|
|
|
|
9 |
p. 2064-2072
|
artikel
|
| 146 |
Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells
|
Thornton, Sherry
|
|
|
|
9 |
p. 545-556
|
artikel
|
| 147 |
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
|
Charalampous, Charalampos
|
|
|
|
9 |
p. 2763-2772
|
artikel
|
| 148 |
Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
|
Davila, Jennifer
|
|
|
|
9 |
p. 1762-1768
|
artikel
|
Tijdschrift beschrijving